OVID Institutional Ownership & Shareholders
OVID THERAPEUTICS INC (OVID) is currently held by 131 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $360.51M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Eventide Asset Management, Llc is currently the largest disclosed institutional shareholder of OVID tracked by InsiderSet, reporting ownership valued at approximately $31.77M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $28.23M, representing an estimated loss of -11.15% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed OVID value among the investors covered in this analysis. Major shareholders include Eventide Asset Management, Llc, Blackrock, Inc., Ra Capital Management, L.P., and several other long-term asset managers with concentrated positions in OVID THERAPEUTICS INC (OVID).
This page ranks the largest institutional OVID shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
131
Total Reported Value
$360.51M
Largest Holder
Eventide Asset Management, Llc
Largest Position
$31.77M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
160
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Eventide Asset Management, Llc | 0.42% | 11,812,241 | $31,774,928 | $28,231,256 | -$3,543,672 | -11.15% | |
| Blackrock, Inc. | 0.00% | 10,823,480 | $29,115,162 | $25,868,117 | -$3,247,045 | -11.15% | |
| Ra Capital Management, L.P. | 0.25% | 10,500,968 | $28,247,604 | $25,097,314 | -$3,150,290 | -11.15% | |
| Affinity Asset Advisors, Llc | 1.33% | 10,144,562 | $27,288,872 | $24,245,503 | -$3,043,369 | -11.15% | |
| Janus Henderson Group Plc | 0.01% | 10,714,000 | $23,731,510 | $25,606,460 | +$1,874,950 | +7.90% | |
| State Street Corp | 0.00% | 7,900,765 | $21,253,058 | $18,882,828 | -$2,370,230 | -11.15% | |
| Vanguard Capital Management Llc | 0.00% | 7,760,114 | $20,874,707 | $18,546,672 | -$2,328,035 | -11.15% | |
| Adar1 Capital Management, Llc | 0.94% | 7,417,479 | $19,953,019 | $17,727,775 | -$2,225,244 | -11.15% | |
| Balyasny Asset Management L.P. | 0.03% | 6,719,076 | $18,074,314 | $16,058,592 | -$2,015,722 | -11.15% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 6,163,781 | $16,580,571 | $14,731,437 | -$1,849,134 | -11.15% | |
| Federated Hermes, Inc. | 0.02% | 5,951,666 | $16,009,982 | $14,224,482 | -$1,785,500 | -11.15% | |
| Braidwell Lp | 0.59% | 5,919,464 | $15,923,358 | $14,147,519 | -$1,775,839 | -11.15% | |
| Geode Capital Management, Llc | 0.00% | 4,072,653 | $10,957,549 | $9,733,641 | -$1,223,908 | -11.17% | |
| Silverarc Capital Management, Llc | 0.93% | 3,101,129 | $8,342,037 | $7,411,698 | -$930,339 | -11.15% | |
| Stempoint Capital Lp | 1.13% | 2,417,283 | $6,502,491 | $5,777,306 | -$725,185 | -11.15% | |
| Ikarian Capital, Llc | 1.00% | 2,269,704 | $6,105,503 | $5,424,593 | -$680,910 | -11.15% | |
| Point72 Asset Management, L.P. | 0.01% | 1,945,727 | $5,234,006 | $4,650,288 | -$583,718 | -11.15% | |
| Sphera Funds Management Ltd. | 0.52% | 1,353,000 | $3,639,570 | $3,233,670 | -$405,900 | -11.15% | |
| Northern Trust Corp | 0.00% | 1,246,139 | $3,352,114 | $2,978,272 | -$373,842 | -11.15% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,140,753 | $3,068,626 | $2,726,400 | -$342,226 | -11.15% | |
| Propel Bio Management, Llc | 1.57% | 1,115,538 | $3,000,797 | $2,666,136 | -$334,661 | -11.15% | |
| Rosalind Advisors, Inc. | 1.12% | 1,107,994 | $2,980,504 | $2,648,106 | -$332,398 | -11.15% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,030,943 | $2,773,237 | $2,463,954 | -$309,283 | -11.15% | |
| Sio Capital Management, Llc | 0.46% | 1,005,334 | $2,704,348 | $2,402,748 | -$301,600 | -11.15% | |
| Nuveen, Llc | 0.00% | 893,254 | $2,402,853 | $2,134,877 | -$267,976 | -11.15% | |
| Two Sigma Investments, Lp | 0.00% | 832,378 | $2,239,097 | $1,989,383 | -$249,714 | -11.15% | |
| Wells Fargo & Company/Mn | 0.00% | 826,206 | $2,222,494 | $1,974,632 | -$247,862 | -11.15% | |
| Orbimed Advisors Llc | 0.04% | 747,000 | $2,009,430 | $1,785,330 | -$224,100 | -11.15% | |
| Boothbay Fund Management, Llc | 0.04% | 737,758 | $1,984,569 | $1,763,242 | -$221,327 | -11.15% | |
| Saturn V Capital Management Lp | 0.26% | 663,060 | $1,783,631 | $1,584,713 | -$198,918 | -11.15% | |
| Ally Bridge Group (Ny) Llc | 2.17% | 624,561 | $1,680,069 | $1,492,701 | -$187,368 | -11.15% | |
| Ubs Group Ag | 0.00% | 458,917 | $1,234,487 | $1,096,812 | -$137,675 | -11.15% | |
| Charles Schwab Investment Management Inc | 0.00% | 444,042 | $1,194,473 | $1,061,260 | -$133,213 | -11.15% | |
| Bank Of New York Mellon Corp | 0.00% | 416,318 | $1,119,897 | $995,000 | -$124,897 | -11.15% | |
| Bank Of America Corp | 0.00% | 409,490 | $1,101,528 | $978,681 | -$122,847 | -11.15% | |
| Dimensional Fund Advisors Lp | 0.00% | 387,767 | $1,043,445 | $926,763 | -$116,682 | -11.18% | |
| Goldman Sachs Group Inc | 0.00% | 332,692 | $894,942 | $795,134 | -$99,808 | -11.15% | |
| Informed Momentum Co Llc | 0.06% | 259,631 | $698,407 | $620,518 | -$77,889 | -11.15% | |
| Atom Investors Lp | 0.06% | 251,836 | $677,439 | $601,888 | -$75,551 | -11.15% | |
| Cibc World Market Inc. | 0.00% | 218,851 | $588,709 | $523,054 | -$65,655 | -11.15% | |
| Parkman Healthcare Partners Llc | 0.05% | 197,947 | $532,477 | $473,093 | -$59,384 | -11.15% | |
| Sei Investments Co | 0.00% | 196,685 | $529,083 | $470,077 | -$59,006 | -11.15% | |
| Citigroup Inc | 0.00% | 191,058 | $513,946 | $456,629 | -$57,317 | -11.15% | |
| Invesco Ltd. | 0.00% | 174,900 | $470,481 | $418,011 | -$52,470 | -11.15% | |
| Rhumbline Advisers | 0.00% | 170,139 | $457,666 | $406,632 | -$51,034 | -11.15% | |
| American Century Companies Inc | 0.00% | 169,382 | $455,638 | $404,823 | -$50,815 | -11.15% | |
| Deutsche Bank Ag\ | 0.00% | 149,391 | $401,862 | $357,044 | -$44,818 | -11.15% | |
| Rafferty Asset Management, Llc | 0.00% | 136,774 | $367,922 | $326,890 | -$41,032 | -11.15% | |
| Velan Capital Investment Management Lp | 0.21% | 130,000 | $349,700 | $310,700 | -$39,000 | -11.15% | |
| Price T Rowe Associates Inc | 0.00% | 125,725 | $339,000 | $300,483 | -$38,517 | -11.36% |
Frequently asked questions about OVID
Who are the largest institutional holders of OVID?
The largest institutional holders of OVID reported in the latest SEC Form 13F filings include Eventide Asset Management, Llc, Blackrock, Inc., Ra Capital Management, L.P., Affinity Asset Advisors, Llc, and Janus Henderson Group Plc. InsiderSet ranks institutional holders by their latest reported OVID position.
What is OVID institutional ownership?
This page tracks OVID positions reported by institutional investment managers through SEC Form 13F. OVID THERAPEUTICS INC (OVID) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own OVID?
InsiderSet currently tracks 131 institutional managers reporting OVID holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of OVID shareholders.
How much OVID stock do institutions own?
Institutional investment managers disclosed approximately $360.51M in OVID holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was OVID institutional ownership last updated?
The latest OVID institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional OVID holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its OVID position after the reporting date.
Are institutions buying or selling OVID?
Institutional buying and selling can be analyzed by comparing OVID positions across consecutive 13F reporting periods. InsiderSet's OVID Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View OVID ownership changes.
How has OVID institutional ownership changed over time?
InsiderSet tracks OVID institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.